HIV-1 Reverse Transcriptase-Specific CTL Against Conserved Epitopes Do Not Protect Against Progression to AIDS

Journal of Immunology

Volumn 159, Issue 7, 1997, Pages 3648-3654

  Van Der Burg, Sjoerd H ^a   Klein, Michèl R ^b   Pontesilli, Oscar ^c   Holwerda, Agnes M ^b   Drijfhout, Jan Wouter ^a   Kast, W Martin ^a,d   Miedema, Frank ^b,c   Melief, Cornelis J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN; HLA ANTIGEN CLASS 1; RNA DIRECTED DNA POLYMERASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ARTICLE; CELL LINE; COHORT ANALYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DISEASE COURSE; ENZYMOLOGY; EPITOPE MAPPING; GENETICS; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SURVIVAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMINO ACID SEQUENCE; CELL LINE; COHORT STUDIES; CONSERVED SEQUENCE; CYTOTOXICITY, IMMUNOLOGIC; DISEASE PROGRESSION; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV-1 REVERSE TRANSCRIPTASE; HLA ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; SURVIVAL ANALYSIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031253703     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650.
2. Klein, M. R., C. A. van Baalen, A. M. Holwerda, S. R. Kerkhof-Garde, R. J. Bende, I. P. N. Keet, J.-K. M. Eeftinck-Schattenkerk, A. D. M. E. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365.
3. + cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms. J. Virol. 71:3120.
4. Greenough, T. C., M. Somasundaran, D. B. Brettler, R. M. Hesselton, A. Alimenti, F. Kirschoff, D. Panicali, and J. L. Sullivan. 1994. Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 10:395.
5. Rinaldo, C., X. L. Huang, Z. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottril, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:5838.
6. Wollinsky, S. M., B. T. M. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, and R. A. Koup. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537.
7. Harrer, T., E. Harrer, S. A. Kalams, P. Barbosa, A. Trocha, R. P. Johnson, T. Elbeik, M. B. Feinberg, S. P. Buchbinder, and B. D. Walker. 1996. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. J. Immunol. 156:2616.
8. Huynen, M. A., and A. U. Neumann. 1996. Rate of killing HIV-infected T cells and disease progression. Science 272:1962.
9. + lymphocyte activity. J. Infect. Dis. 172:329.
10. Hadida, F., G. Haas, N. Zimmerman, A. Hosmalin, R. Spohn, R. Jung, P. Debre, and B. Autran. 1995. Cytotoxic T lymphocytes from lymphoid organs recognize an optimal HLA-A2 and B52 restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 nef. J. Immunol. 154:4174.
11. + cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. J. Virol. 65:4051.
12. Harrer, E., T. Harrer, S. Buchbinder, D. L. Mann, M. Feinberg, T. Yilma, R. P. Johnson, and B. D. Walker. 1994. HIV-1 specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons. AIDS Res. Hum. Retroviruses 10:S77.
13. Dupuis, M., S. K. Kundu, and T. C. Merigan. 1995. Characterization of HLA-A*0201 restricted cytotoxic T cell epitopes in conserved regions of the HIV type 1 gp160 protein. J. Immunol. 155:2232.
14. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenennan, B. Koppe, K. Sigmund, C. R. M. Bangham, and A. J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606.
15. Nowak, M. A., and C. R. M. Bangham. 1996. Population dynamics of immune responses to persistent viruses. Science 272:74.
16. + T cells from seropositive individuals: identification of CTL epitopes and precursor frequencies. AIDS 7:781.
17. van der Burg, S. H., M. R. Klein, C. J. H. van de Velde, W. M. Kast, F. Miedema, and C. J. M. Melief. 1995. Induction of a primary CTL response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase. AIDS 9:121.
18. Walker, B. D., C. Flexner, T. J. Paradis, T. C. Fuller, M. S. Hirsch, R. T. Schooley, and B. Moss. 1988. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240:64.
19. De Wolf, F., J. Goudsmit, D. A. Paul, J. M. A. Lange, C. Hooijkaas, P. T. A. Schellekens, R. A. Coutinho, and J. van der Noordaa. 1987. Risk of AIDS related complex and AIDS in homosexual men with persistent HIV anti-genaemia. Br. Med. J. 295:569.
20. Korbel, B., R. Koup, B. Walker, B. Haynes, J. Moore, and G. Myers, eds. 1995. HIV Molecular Immunological Database. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM.
21. Strijbosch, L. W. G., W. A. Buurman, R. J. M. M. Does, P. H. Zinken, and G. Groenewegen. 1987. Limiting dilution assays: experimental design and statistical analysis. J. Immunol. Methods 97:133.
22. Harrer, E., T. Harrer, P. Barbosa, M. Feinberg, R. P. Johnson, S. Buchbinder, and B. D. Walker. 1996. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2 restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. J. Infect. Dis. 173:476.
23. Walker, B. D., C. Flexner, K. Birch-Limberger, L. Fisher, T. J. Paradis, A. Aldovini, R. Young, B. Moss, and R. T. Schooley. 1987. Long-term culture and line specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:9514.
24. Rammensee, H. G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
25. Johnson, R. P., and B. D. Walker. 1991. Identification of HIV-1 cytotoxic T-lymphocyte epitopes and implications for vaccine development. Biotechnol. Ther. 2:137.
26. Boisgerault, F., I. Khalil, V. Tieng, F. Connan, T. Tabary, J. H. M. Cohen, J. Choppin, D. Charron, and A. Toubert. 1996. Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy. Proc. Natl. Acad. Sci. USA 93:3466.
27. Goulder, P. J. R., M. Bunce, P. Krausa, K. McIntyre, S. Crowley, B. Morgan, A. Edwards, P. Giangrande, R. E. Phillips, and A. J. McMichael. 1996. Novel, cross-restricted, conserved and immunodominant CTL epitopes in slow progressors in HIV-1 infection. AIDS Res. Hum. Retroviruses 12:1691.
28. Johnson, R. P., A. Trocha, L. Yang, G. P. Mazzara, D. L. Panicali, T. M. Buchanan, and B. D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes: fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J. Immunol. 147:1512.
29. Huang, Y., W. A. Paxton, S. M. Wolinsky, A. U. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, K. Kunstman, D. Erickson, E. Dragon, N. R. Landau, J. Phair, D. D. Ho, and R. A. Koup. 1996. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2:1240.
30. Deacon, N. J., A. Tsykin, A. Solomin, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, C. Chatfield, V. A. Lawson, S. Crowe, A. Maerz, S. Sonza, J. Learmont, J. S. Sullivan, A. Cunningham, D. Dwyer, D. Dowton, and J. Mills. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988.
31. De Maria, A., C. Cirillo, and L. Moretta. 1994. Occurrence of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T cell activity in apparently uninfected children born to HIV-1 infected mothers. J. Infect. Dis. 170:296.
32. Langlade Demoyen, P., N. Ngo-Giang-Huong, K. Ferchal, and E. Oksenhendler. 1994. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV infected patients. J. Clin. Invest. 93:1293.
33. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59.
34. Travers, K., S. Mboup, R. Marlink, A. Gueye-Ndiaye, T. Siby, I. Thior, I. Traore, A. Dieng-Sarr, J. L. Sankale, C. Mullins, I. Ndoye, C. C. Hsieh, M. Essex, and P. Kanki. 1995. Natural protection against HIV-1 infection provided by HIV-2. Science 268:1612.
35. Rowland-Jones, S. L., and A. McMichael. 1995. Immune responses in HIV-exposed seronegatives: have they repelled the virus?. Curr. Opin. Immunol. 7: 448.
36. Pulkonen, P., L. Walther, Y. J. Zhang, C. Nilsson, J. Albert, P. Biberfeld, R. Thorstensson, and G. Biberfeld. 1995. Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine. Nat. Med. 1:914.
37. Kaslow, R. A., M. Carrington, R. Apple, L. Park, A. Munoz, A. J. Saah, J. J. Goedert, C. Winkler, S. J. O'Brien, C. Rinaldo, R. Detels, W. Blattner, J. Phair, H. Erlich, and D L. Mann. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med 2:405.